Profil de l'entreprise · Healthcare

Straumann Holding AG

STMN · SW
Bourse
SW
Pays / Région
Switzerland
Effectif
11 319
Cours actuel
106.8
clôture du 27 juin 2026
Achat raisonnable
76
Point d'entrée avec marge de sécurité
Score de croissance Baillie
53/100
Moyen
Valeur intrinsèque · Fourchette en trois niveaux Cours actuel 106.8 · Dans la fourchette de valeur intrinsèque raisonnable

Fourchette de valorisation composite · prudent 70–76 / raisonnable 85–129 / optimiste 134–145. À 106.8, Dans la fourchette de valeur intrinsèque raisonnable.

17 juin 2026 Earnings Needs review

Straumann raised 2026 profitability outlook

Straumann raised its 2026 core EBIT margin expansion outlook, citing lower-than-expected tariffs and faster efficiency gains.

Possible impact:May affect expectations for full-year profitability and earnings upgrades.

The Wall Street JournalView source

Automatically summarized from public sources; for context only, not investment advice.

Capitalisation16,5 Md CHF
Chiffre d'affaires (TTM)2,61 Md CHF
EBITDA750,57 M CHF
Marge nette13,66 %
ROE17,01 %
PER (TTM)46,39
PER prévisionnel32,79
PEG1,58
BPA2,23 CHF
Rendement du dividende0,95 %
Fourchette sur 52 semaines72,22 CHF – 110,27 CHF

Données EODHD, présentées dans la devise de reporting ; à titre indicatif uniquement, ne constitue pas un conseil en investissement.

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Historique

Bientôt disponibleCette section est en cours de complétion ; revenez bientôt.

Position dans le secteur

Bientôt disponibleCette section est en cours de complétion ; revenez bientôt.

Pas encore d'analyse sur cette valeur dans votre langue.